What's going on with the Wesfarmers (ASX:WES) API takeover bid?

API recently reported its FY21 result. What's happening with the Wesfarmers offer?

| More on:
Multiple ASX share investors take on one another in a tug of war in a high rise building.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some time has passed since the first Wesfarmers Ltd (ASX: WES) bid for Australian Pharmaceutical Industries Ltd (ASX: API). What's going on?

API recently announced its FY21 result for the 12 months to 31 August 2021. The business gave an update about the takeover offers on the table.

Timeline of events for API and Wesfarmers

In the middle of July 2021, API announced that it had received an unsolicited, conditional, non-binding and indicative offer from Wesfarmers at $1.38 cash per share. A couple of weeks later, API decided to reject that offer.

Then, in the middle of September 2021, API said that it had received a revised offer from Wesfarmers of $1.55 cash per share and that confirmatory due diligence would commence.

However, then another player decided to make it a takeover battle. API received an offer from Sigma Healthcare Ltd (ASX: SIG) for API of 2.05 Sigma shares and $0.35 cash per API share.

Then, on 7 October, Wesfarmers announced it had exercised the option it had with Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) to buy 19.3% of API.

What are the next steps?

The next phase of the takeover fight could have an important effect on the API share price and the Wesfarmers share price.

API said that it hadn't received and agreed to a final offer from either Wesfarmers or Sigma.

However, it did confirm that due diligence has concluded and negotiations are continuing.

API noted that it would continue to tell the market about what's happening.

FY21 result

API told the market that total revenue was $4 billion, being slightly down by 0.4%. Underlying earnings before interest and tax (EBIT) was $27.8 million., up 15.3%. The underlying net profit rose 25% to $$39.3 million.

API said that prescription medicine sales grew 3.6%, reflecting the resilience its pharmacy business

However, COVID-19 lockdowns closed all of its non-pharmacy price. API also said that it continues to make progress on its NSW distribution centre.

Outlook from API

API said that both retail businesses have bounced back strongly after the lockdowns and the Priceline Pharmacy has done over 250,000 vaccinations.

The FY22 pipeline of potential Priceline Pharmacy franchisees is the strongest it has been for the past three years.

API outlined around $20 million of profit improvements over the next couple of years, thanks to recalibration of Priceline company stores, a new automated distribution centre, an exit of consumer brands manufacturing and a return of Pfizer to CSO wholesales.

The pharmacy company also said that it has mostly achieved acceptable rental outcomes with its CBD landlords.

In total, the company is expecting to open a minimum of 20 new Priceline Pharmacy stores in FY22.

Why does Wesfarmers want to buy API?

If Wesfarmers is successful, it sees opportunities to invest to strengthen the competitive position of API, improving supply chain capabilities and enhancing the online experience for customers.

The ASX share said that API would also form the basis of a new healthcare division of Wesfarmers and a platform from which to invest add develop capabilities in the growing health, wellbeing and beauty sector.

At the current Wesfarmers share price, it is valued at 29x FY22's estimated earnings.

Motley Fool contributor Tristan Harrison owns shares of Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Washington H. Soul Pattinson and Company Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Industrials Shares

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Mergers & Acquisitions

Why are Brickworks shares up 18% today?

Let's find out what is getting investors excited this morning.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Broker Notes

How this undervalued ASX All Ords share could rocket 80% in a year

A leading fund manager expects a big turnaround for this beaten-down ASX All Ords stock.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Industrials Shares

Key takeaways from ALS shares results according to Macquarie

ALS announced an underlying net profit after tax (NPAT) of $312 million this week.

Read more »

A woman sits crossed legged on seats at an airport holding her ticket and smiling.
Industrials Shares

What does Macquarie think Auckland International Airport shares are worth?

Is it time to invest in this unique holding?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Industrials Shares

Guess which ASX 200 share is down 8% on earnings miss

Why are investors selling this stock? Let's dig deeper into things.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.
Broker Notes

Macquarie tips 20% upside for this ASX 200 industrials stock

Let's see what the broker is saying about this stock following an update.

Read more »

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
Industrials Shares

Guess which ASX 200 stock is crashing 24% on results day

Investors were not impressed with this result. But why?

Read more »

A man looking at his laptop and thinking.
Industrials Shares

Which ASX 200 industrials stock does Macquarie expect to sink 40% over the next 12 months?

Can this name build it's way out of such negative sentiment?

Read more »